Study Background and Disease Burden
Acute intracerebral hemorrhage (ICH) remains a devastating form of stroke worldwide, with high mortality and morbidity rates and a significant burden on healthcare systems, particularly in low- and middle-income countries. Early intensive management to mitigate secondary brain injury is critical yet complex, involving modulation of several physiological parameters. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT3) demonstrated that a care bundle approach, integrating rapid control of elevated blood pressure (BP), glucose, and temperature alongside anticoagulation reversal, significantly improved functional outcomes of patients after ICH.
However, while INTERACT3 proved the overall efficacy of the bundled intervention, the relative contribution of each component to the observed clinical benefit remained unclear. Clinicians and policymakers require clarity on which care elements are most crucial to optimize resource allocation, particularly in settings with limited healthcare infrastructure.
